81 related articles for article (PubMed ID: 12404880)
1. Pharmacokinetic interaction between TAK-044, a new endothelin antagonist, and ciclosporin in rats.
Maeshiba Y; Yamashita K; Tsukuda R; Yoshimura Y
Arzneimittelforschung; 2002; 52(9):664-8. PubMed ID: 12404880
[TBL] [Abstract][Full Text] [Related]
2. Disposition of TAK-044, a new endothelin antagonist, in rats and dogs.
Maeshiba Y; Takeuchi T; Kondo T; Yamashita K; Tsukuda R; Yoshimura Y
Arzneimittelforschung; 2002; 52(8):587-92. PubMed ID: 12236045
[TBL] [Abstract][Full Text] [Related]
3. Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in human endothelinA and endothelinB receptors.
Masuda Y; Sugo T; Kikuchi T; Kawata A; Satoh M; Fujisawa Y; Itoh Y; Wakimasu M; Ohtaki T
J Pharmacol Exp Ther; 1996 Nov; 279(2):675-85. PubMed ID: 8930171
[TBL] [Abstract][Full Text] [Related]
4. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs.
Tagawa Y; Kiyota Y; Yoshimura Y; Motohashi M; Tanayama S
Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376
[TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
7. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition by TAK-044 of the inotropic effects of endothelin-1 and endothelin-3.
Yomogida S; Maruya J; Norota I; Ishii K; Endoh M
Eur J Pharmacol; 2004 May; 492(2-3):217-24. PubMed ID: 15178368
[TBL] [Abstract][Full Text] [Related]
9. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
10. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
[TBL] [Abstract][Full Text] [Related]
11. Nonlinear pharmacokinetics of TAK-044, a new endothelin antagonist, in rats.
Takeuchi T; Tagawa Y; Hagihara K; Maeshiba Y; Yamashita K; Tsukuda R; Yoshimura Y
Biopharm Drug Dispos; 2001 Sep; 22(6):221-30. PubMed ID: 11754038
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
Nonaka K; Tsujioka T; Tougou K; Mukai H
Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats.
Dong J; Yu X; Wang L; Sun YB; Chen XJ; Wang GJ
Acta Pharmacol Sin; 2008 Oct; 29(10):1247-52. PubMed ID: 18817631
[TBL] [Abstract][Full Text] [Related]
17. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
Mukai H; Watanabe S; Morino A
Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
[TBL] [Abstract][Full Text] [Related]
19. Effect of its demethylated metabolite on the pharmacokinetics of unchanged TAK-603, a new antirheumatic agent, in rats.
Tagawa Y; Miwa K; Tsukuda R; Yoshimura Y; Tanayama S; Tanigawara Y
Drug Metab Dispos; 1999 Apr; 27(4):495-501. PubMed ID: 10101145
[TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
